Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

Summary

The purpose of the study is to collect long-term data on the inhibitor development rate of Human-cl rhFVIII in previously untreated patients with severe Hemophilia A.

Timeline

Start

2014-04

Primary completion

2018-12-27

Completion

2018-12-27

Drugs

Indications